908 Devices (MASS) Liabilities from Discontinued Operations (2024)
908 Devices' (MASS) quarterly Liabilities from Discontinued Operations came in at 4696000.0 in Q4 2024.
908 Devices (MASS) Liabilities from Discontinued Operations (2024) Analysis & Trends
908 Devices (MASS) has 1 years of Liabilities from Discontinued Operations data on file, last reported at 4696000.0 in Q4 2024.
- On a quarterly basis, Liabilities from Discontinued Operations changed N/A year-over-year to 4696000.0 in Q4 2024; TTM through Dec 2024 was 4696000.0, a N/A change from a year earlier, with the FY2024 full-year figure at 4696000.0, changed N/A from the prior year.
- Liabilities from Discontinued Operations for Q4 2024 stood at 4696000.0.
- Over the last five years, Liabilities from Discontinued Operations for MASS reached as high as 4696000.0 in Q4 2024 and fell as low as 4696000.0 in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - |
| 10 | 908 Devices | 261.78 Mn | 150.04 Mn | 6.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 4.70 Mn |
| Dec 31, 2024 | 4.70 Mn |